ANI PHARMACEUTICALS Files 8-K on Material 8-K Items
ANI PHARMACEUTICALS filed an 8-K dated 2026-08-24 covering director or officer departures, elections, or compensatory arrangements; financial statements and exhibits.
$ANIP+WL: leadership/succession risk — watch guidance and the next 8-K/exhibits. NFA.